Shenzhen RuiJin Pharmaceutical Co.,Ltd 86-188-06592208
Lorcaserin HCL CAS 616202-92-7

Lorcaserin HCL CAS 616202-92-7

  • High Light

    CAS 616202-92-7


    Lorcaserin HCL Weight Loss Steroids


    Lorcaserin Hydrochloride Weight Loss Steroids

  • Name
    Lorcaserin HCL
  • CAS
  • MF
  • MW
  • Boiling Point
    288.125°C At 760 MmHg
  • Flash Point
  • Email
  • Whatsapp
  • Place of Origin
  • Brand Name
  • Certification
  • Model Number
  • Minimum Order Quantity
  • Price
  • Packaging Details
    Disguised package or according to your requirement
  • Delivery Time
    within 24 hours after payment
  • Payment Terms
    Western union and moneygram,Bank transfer,Bitcoin, T/T
  • Supply Ability

Lorcaserin HCL CAS 616202-92-7

Lorcaserin HCL CAS :616202-92-7


Quick Detail :


Product Name: Lorcaserin Hcl

English name: Lorcaserin hydrochloride
English Synonyms: (1R) -8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride; APD 356; APD-356; UNII-0QJF08GDPE; Lorcaserin HCl; (R) – 1H-3-Benzazepine, 8-Chloro-2,3,4,5-Tetrahydro-1-Methyl-, Hydrochloride

Appearance:white powder

Boiling point : 288.125°C at 760 mmHg
Flash point : 128.054°C
Product usage : Medicine reducing weight and antidepressants


Product name





yellow oil


Molecular formula


Molecular weight


Molecular Structure

Lorcaserin HCL CAS 616202-92-7 0

Boiling point

288.125oC at 760 mmHg

Refractive index



1.075 g / cm3




Related product lists:



T3 /Liothyronine sodium/Cytomel CAS 55-06-1
T4/L-Thyroxine CAS 51-48-9
L-Carnitine CAS 541-15-1
DMAA CAS 13803-74-2
Theobromine CAS 83-67-0
Synephrine CAS 94-07-5
Rimonabant CAS 168273-06-1
Lorcaserin HCI CAS 846589-98-8
CLA (Conjugated Linoleic Acid) CAS 2420-56-6
Orlistat CAS 96829-58-2
Furazabol CAS 12B9-29-8
Calcium Pyruvate CAS 52009-14-0
Dextromethorphan Hydrobromide CAS 6700-34-1
Lorcaserin hydrochloride CAS 846589-98-8
Telmisartan CAS 144701-48-4



Lorcaserin HCl For Weight Loss:


Lorcaserin is a new drug for the treatment of obesity , belonging to oral potent selective serotonin 2C receptor agonists, lorcaserin hydrochloride is successfully developed by the US company Arena, on June 27, 2012 by the US FDA it is approved for marketing, as adjuvant therapy for obesity or merge with at least one weight-related complications in overweight adults in low-calorie diet and exercise basis . Clinical studies show that the drug can reduce weight of obesity and overweight patients ,it can improve obesity-related metabolic parameters, and it is well tolerated. Lorcaserin affinity for the 5-HT2c 100 times higher than the 5-HT2B (valvular heart disease risk) ,it has good safety,it is the first FDA-approved weight-loss drug after 1999 . In a year of Lorcaserin treatment, the average weight loss ranges from 3 to 3.7 percent.



How should Lorcaserin HCl be used?


  • Lorcaserin comes as a tablet and as an extended-release (long-acting) tablet to take by mouth. The tablets are usually taken with or without food twice a day. The extended-release tablets are usually taken with or without food once a day. Take lorcaserin at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lorcaserin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
  • Swallow the extended-release tablets whole; do not split, chew, or crush them.
  • Lorcaserin may be habit forming. Do not take a larger dose, take it more often, or take it for a longer period of time than prescribed by your doctor.
  • If you do not lose a certain amount of weight during the first 12 weeks of your treatment, it is not likely that you will benefit from taking lorcaserin. Your doctor may tell you to stop taking lorcaserin if you do not lose enough weight during the first 12 weeks of your treatment.
  • Lorcaserin will help control your weight only if you continue to take it. Do not stop taking lorcaserin without talking to your doctor.
  • Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.